AR and prostate cancer: For example, AU-15330 induced a potent inhibitor of tumor growth in xenograft models of prostate cancer, and synergized with the androgen receptor antagonist enzalutamide, even inducing disease remission in castration-resistant prostate cancer models without toxicity [60].